Jaguar Health, Inc. (NASDAQ:JAGX)

PRESS RELEASE

published on 08/14/2025 at 14:00, 5 months 16 days ago

Jaguar Health Reports Second Quarter 2025 Financials: Net Q2 2025 Revenue Up Approximately 35% Versus Net Q1 2025 Revenue
Jaguar Health, Inc. reports 35% revenue increase in Q2 2025 for prescription & non-prescription products, including license revenue. Mytesi prescription volume up 6.5%. Crofelemer trial yields positive results

Jaguar Health Inc. FDA Meeting Crofelemer Trial Q2 2025 Revenue Mytesi Prescription Volume
BRIEF

published on 08/12/2025 at 15:05, 5 months 18 days ago

Jaguar Health Announces Investor Webcast on August 14, 2025

Financial Results Pharmaceuticals Investor Webcast Jaguar Health Lisa Conte
BRIEF

published on 08/12/2025 at 15:05, 5 months 18 days ago

Jaguar Health annonce un webcast destiné aux investisseurs le 14 août 2025

Résultats Financiers Jaguar Health Lisa Conte Médicaments Webcast Pour Les Investisseurs
PRESS RELEASE

published on 08/12/2025 at 15:00, 5 months 18 days ago

Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8:30 AM Eastern Regarding Q2 2025 Financials & Corporate Updates
Jaguar Health, Inc. to conduct investor webcast on August 14, 2025 to review Q2 financials and corporate updates. CEO Lisa Conte presenting at Emerging Growth Conference on August 20, 2025

Investor Webcast Lisa Conte Emerging Growth Conference Jaguar Health Inc. Q2 Financials
BRIEF

published on 07/10/2025 at 14:35, 6 months 20 days ago

Jaguar Health étend son étude sur Canalevia-CA1 pour chiens

Jaguar Health Canalevia-CA1 Santé Animale Approbation De La FDA Diarrhée Du Chien
BRIEF

published on 07/10/2025 at 14:35, 6 months 20 days ago

Jaguar Health Expands Study on Canalevia-CA1 for Dogs

FDA Approval Jaguar Health Canalevia-CA1 Animal Health Dog Diarrhea
PRESS RELEASE

published on 07/10/2025 at 14:30, 6 months 20 days ago

Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs
Jaguar Health, Inc. in talks with animal health partners to bring Canalevia to global market for general diarrhea in dogs. CEO presents at conference to discuss updates on Canalevia-CA1

Jaguar Health Conference Canalevia Animal Health Partners General Diarrhea
BRIEF

published on 07/08/2025 at 15:05, 6 months 22 days ago

Le Pérou accorde les droits de recherche sur la coca à Magdalena Biosciences

Jaguar Health Magdalena Biosciences Santé Mentale Recherche Sur La Coca Partenariat Avec Le Pérou
BRIEF

published on 07/08/2025 at 15:05, 6 months 22 days ago

Peru Grants Coca Research Rights to Magdalena Biosciences

Mental Health Jaguar Health Magdalena Biosciences Coca Research Peru Partnership
PRESS RELEASE

published on 07/08/2025 at 15:00, 6 months 22 days ago

Coca Access and Benefit Sharing Agreement Authorized by Peru's National Institute of Agrarian Innovation (INIA) Supports Research Efforts of Jaguar Health and Filament Health Joint Venture, Magdalena Biosciences, into Potential Mental Health and CNS Indic
Jaguar Health announces agreement for research on coca plants to develop plant-based drugs for mental health and CNS indications, focusing on fair benefits sharing and traditional medicine

Mental Health Jaguar Health Coca Plants Plant-based Drugs Benefits Sharing

Published on 01/31/2026 at 03:15, 3 hours 41 minutes ago

Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 4 hours 36 minutes ago

Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 5 hours 16 minutes ago

Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/31/2026 at 00:00, 6 hours 56 minutes ago

BE Resources Announces Private Placement
Published on 01/30/2026 at 23:00, 7 hours 56 minutes ago

Avidian Gold Corp. Announces Director Resignation

View all ACCESSWIRE

Published on 01/31/2026 at 02:45, 4 hours 10 minutes ago

CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 8 hours 56 minutes ago

Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 10 hours 45 minutes ago

Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 20:09, 10 hours 46 minutes ago

Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 20:07, 10 hours 48 minutes ago

Aroundtown SA successfully issued AUD 600 million bonds in two tranches

View all EQS

Published on 01/30/2026 at 18:40, 12 hours 16 minutes ago

ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 18:01, 12 hours 55 minutes ago

Emova Group - Résultats annuels 2024/25
Published on 01/30/2026 at 17:45, 13 hours 11 minutes ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 13 hours 11 minutes ago

Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 22 hours 26 minutes ago

Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés

View all LES ECHOS COMFI WIRE

News